Crinetics Pharmaceuticals, Inc. (CRNX) Ownership

$40.86

south_east
-$0.65 (-1.57%)
Day's range
$40.33
Day's range
$42.01

Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 14.19 M $590.91 M   0.44% 15.13%
VANGUARD GROUP INC 11/07/2025 9.17 M $381.94 M   -0.93% 9.78%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 8.38 M $349.11 M   44.34% 8.94%
BLACKROCK, INC. 11/12/2025 7.59 M $315.98 M   2.26% 8.09%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 6.48 M $269.96 M   1.27% 6.91%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2025 5.77 M $240.32 M   24.19% 6.15%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 5.31 M $221.01 M   -5.08% 5.66%
ECOR1 CAPITAL, LLC 11/14/2025 4.29 M $178.60 M   0.00% 4.57%
JANUS HENDERSON GROUP PLC 11/14/2025 3.86 M $160.70 M   13.15% 4.11%
PARADIGM BIOCAPITAL ADVISORS LP 11/14/2025 2.55 M $106.24 M   8.84% 2.72%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 2.28 M $94.93 M   2.96% 2.43%
STATE STREET CORP 11/14/2025 2.21 M $91.95 M   -31.53% 2.35%
JENNISON ASSOCIATES LLC 10/30/2025 2.04 M $85.16 M   2.90% 2.18%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 2.00 M $83.44 M   0.26% 2.14%
SIREN, L.L.C. 11/13/2025 1.69 M $70.33 M   0.00% 1.80%
NOVO HOLDINGS A/S 11/14/2025 1.63 M $67.68 M   4.84% 1.73%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 1.47 M $61.03 M   22.06% 1.56%
JPMORGAN CHASE & CO 11/26/2025 1.26 M $52.43 M   279.18% 1.34%
AMERICAN CENTURY COMPANIES INC 11/12/2025 1.13 M $47.21 M   33.57% 1.21%
ORBIMED ADVISORS LLC 11/14/2025 1.10 M $45.77 M   -4.35% 1.17%
FIRST LIGHT ASSET MANAGEMENT, LLC 11/14/2025 941.52 K $39.21 M   8.95% 1.00%
CITADEL ADVISORS LLC 11/14/2025 884.51 K $36.84 M   35.32% 0.94%
HOOD RIVER CAPITAL MANAGEMENT LLC 11/14/2025 883.00 K $36.78 M   -0.62% 0.94%
RTW INVESTMENTS, LP 11/14/2025 872.39 K $36.33 M   86.81% 0.93%
GW&K INVESTMENT MANAGEMENT, LLC 11/12/2025 850.55 K $35.43 M   -12.39% 0.91%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 11/07/2025 834.03 K $34.74 M   17.02% 0.89%
NORTHERN TRUST CORP 11/14/2025 809.89 K $33.73 M   3.27% 0.86%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 778.65 K $32.43 M   1.62% 0.83%
FISHER ASSET MANAGEMENT, LLC 11/12/2025 758.36 K $31.59 M   2.89% 0.81%
VESTAL POINT CAPITAL, LP 11/14/2025 750.00 K $31.24 M   -50.00% 0.80%
CANDRIAM S.C.A. 11/06/2025 745.09 K $31.03 M   7.38% 0.79%
GOLDMAN SACHS GROUP INC 11/14/2025 713.13 K $29.70 M   -20.84% 0.76%
MORGAN STANLEY 11/14/2025 682.13 K $28.41 M   -10.25% 0.73%
AMERIPRISE FINANCIAL INC 11/14/2025 614.82 K $25.61 M   157.67% 0.66%
BANK OF AMERICA CORP /DE/ 11/14/2025 601.04 K $25.03 M   4.84% 0.64%
NUVEEN, LLC 11/12/2025 544.75 K $22.69 M   3.77% 0.58%
FIERA CAPITAL CORP 11/07/2025 435.43 K $18.14 M   -2.00% 0.46%
UBS GROUP AG 11/13/2025 407.72 K $16.98 M   27.20% 0.43%
CORMORANT ASSET MANAGEMENT, LP 11/14/2025 400.00 K $16.66 M   0.00% 0.43%
BANK OF NEW YORK MELLON CORP 11/03/2025 399.63 K $16.64 M   15.53% 0.43%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 10/30/2025 387.93 K $16.16 M   13.53% 0.41%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 377.80 K $15.74 M   115.57% 0.40%
ABRDN PLC 11/07/2025 339.95 K $14.16 M   21.26% 0.36%
PROSIGHT MANAGEMENT, LP 11/14/2025 328.68 K $13.69 M   10.25% 0.35%
ENSIGN PEAK ADVISORS, INC 11/13/2025 295.01 K $12.29 M   -6.51% 0.31%
BAKER BROS. ADVISORS LP 11/14/2025 280.00 K $11.66 M   0.00% 0.30%
CHECKPOINT CAPITAL L.P. 11/14/2025 260.00 K $10.83 M   100.00% 0.28%
IKARIAN CAPITAL, LLC 11/14/2025 257.70 K $10.73 M   100.00% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 257.51 K $10.73 M   101.71% 0.27%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2025 248.37 K $10.34 M   367.52% 0.26%

Crinetics Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 288 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:

FMR LLC: 14.19 M

VANGUARD GROUP INC: 9.17 M

WELLINGTON MANAGEMENT GROUP LLP: 8.38 M

BlackRock, Inc.: 7.59 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 6.48 M

FARALLON CAPITAL MANAGEMENT LLC: 5.77 M

114.83% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 115.33 M shares in the last 24 months. This purchase volume represents approximately $4.71 B in transactions.